• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因宫颈癌死亡的时间及其在住院患者中的预测因素:巴西马托格罗索州的一项生存方法研究。

Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.

机构信息

Institute of Collective Health, Federal University of Mato Grosso, Av. Fernando Correa da Costa, nº 2367 - Bairro Boa Esperança, Cuiabá, Mato Grosso, 78060-900, Brazil.

State Secretary of Health of Mato Grosso, Cuiabá, Mato Grosso, Brazil.

出版信息

World J Surg Oncol. 2024 Oct 9;22(1):269. doi: 10.1186/s12957-024-03518-y.

DOI:10.1186/s12957-024-03518-y
PMID:39385163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11463162/
Abstract

BACKGROUND

Cervical cancer (CC) is a serious public health concern, being the fourth most common cancer among women and a leading cause of cancer mortality. In Brazil, many women are diagnosed late, and in Mato Grosso, with its geographical diversity, there are specific challenges. This study analyzed hospital survival and its predictors using data from the Hospital Information System (SIH) of the Unified Health System (SUS) in Mato Grosso from 2011 to 2023.

METHODS

Cox regression and Kaplan-Meier models were applied to determine survival time and identify mortality predictors. The adjusted Hazard Ratio (AHR) with a 95% Confidence Interval (CI) was used to measure the association between the factors analyzed.

RESULTS

The hospital mortality rate was 9.88%. The median duration of hospitalization was 33 days (interquartile range [IQR]: 12-36), with a median survival of 43.7%. Patients were followed up for up to 70 days. In the multivariable Cox model, after adjusting for potential confounders, the risk of death during hospitalization was higher in patients aged 40-59 years (AHR = 1.39, p = 0.027) and 60-74 years (AHR = 1.54, p = 0.007), in the absence of surgical procedures (AHR = 4.48, p < 0.001), in patients with medium service complexity (AHR = 2.40, p = 0.037), and in the use of ICU (AHR = 4.97, p < 0.001). On the other hand, patients with hospital expenses above the median (152.971 USD) showed a reduced risk of death (AHR = 0.21, p < 0.001).

CONCLUSION

This study highlights that hospitalized CC patients have reduced survival, underscoring the need for interventions to improve care, including strategies for early diagnosis and expanded access to adequately resourced health services.

摘要

背景

宫颈癌(CC)是一个严重的公共卫生问题,是女性中第四常见的癌症,也是癌症死亡的主要原因。在巴西,许多女性被诊断为晚期,而在地理多样性的马托格罗索州,存在着具体的挑战。本研究使用马托格罗索州统一卫生系统(SUS)医院信息系统(SIH)的数据,从 2011 年至 2023 年分析了医院生存率及其预测因素。

方法

应用 Cox 回归和 Kaplan-Meier 模型确定生存时间并确定死亡率预测因素。使用调整后的危害比(AHR)和 95%置信区间(CI)来衡量分析因素之间的关联。

结果

医院死亡率为 9.88%。住院中位数为 33 天(四分位距 [IQR]:12-36),中位生存时间为 43.7%。患者随访最长可达 70 天。在多变量 Cox 模型中,在校正了潜在混杂因素后,40-59 岁(AHR=1.39,p=0.027)和 60-74 岁(AHR=1.54,p=0.007)的患者住院期间死亡风险较高,无手术(AHR=4.48,p<0.001),中等服务复杂性(AHR=2.40,p=0.037),使用 ICU(AHR=4.97,p<0.001)。另一方面,住院费用高于中位数(152.971 美元)的患者死亡风险降低(AHR=0.21,p<0.001)。

结论

本研究强调,住院的 CC 患者生存率降低,这表明需要采取干预措施来改善护理,包括早期诊断和扩大获得资源充足的卫生服务的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5944/11463162/6b1f2406d7d3/12957_2024_3518_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5944/11463162/3fe672bd6581/12957_2024_3518_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5944/11463162/6b1f2406d7d3/12957_2024_3518_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5944/11463162/3fe672bd6581/12957_2024_3518_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5944/11463162/6b1f2406d7d3/12957_2024_3518_Fig2_HTML.jpg

相似文献

1
Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.因宫颈癌死亡的时间及其在住院患者中的预测因素:巴西马托格罗索州的一项生存方法研究。
World J Surg Oncol. 2024 Oct 9;22(1):269. doi: 10.1186/s12957-024-03518-y.
2
Survival status and predictors of mortality among cervical cancer patients at oncologic centers in Addis Ababa, Ethiopia: a follow up study.在埃塞俄比亚亚的斯亚贝巴的肿瘤中心,宫颈癌患者的生存状况和死亡预测因素:一项随访研究。
BMC Cancer. 2024 Jun 20;24(1):750. doi: 10.1186/s12885-024-12518-w.
3
Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis.2014 年至 2019 年提克里阿贝贝萨专科医院宫颈癌患者死亡时间的预测因素:生存分析。
PLoS One. 2022 Feb 24;17(2):e0264369. doi: 10.1371/journal.pone.0264369. eCollection 2022.
4
Factors associated with death among cancer patients hospitalized for COVID-19 in Mato Grosso, Brazil.巴西马托格罗索州因 COVID-19 住院的癌症患者死亡相关因素。
Rev Bras Epidemiol. 2022 Jun 24;25(Supl 1):e220020. doi: 10.1590/1980-549720220020.supl.1. eCollection 2022.
5
Cervical cancer specific survival in Grande Cuiabá, Mato Grosso State, Brazil.巴西马托格罗索州大库亚巴的宫颈癌特异性生存。
Rev Bras Epidemiol. 2022 Jun 24;25(Supl 1):e220017. doi: 10.1590/1980-549720220017.supl.1. eCollection 2022.
6
In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil.新型冠状病毒肺炎(COVID-19)导致的住院死亡率及出院后的严重后果:一项来自巴西的前瞻性多中心研究
Lancet Reg Health Am. 2022 Jul;11:100244. doi: 10.1016/j.lana.2022.100244. Epub 2022 Apr 12.
7
Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.从死亡时间到在埃塞俄比亚西北费莱吉比绍特综合专科医院的宫颈癌患者的预测因素:基于设施的回顾性随访研究。
PLoS One. 2022 Jun 24;17(6):e0269576. doi: 10.1371/journal.pone.0269576. eCollection 2022.
8
Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.基于医院的研究:埃塞俄比亚 COVID-19 患者的生存分析。
PLoS One. 2022 May 9;17(5):e0268280. doi: 10.1371/journal.pone.0268280. eCollection 2022.
9
Colorectal cancer survival in Greater Cuiabá, state of Mato Grosso, Brazil.巴西马托格罗索州大库亚巴的结直肠癌生存状况。
Rev Bras Epidemiol. 2023 Mar 27;26:e230022. doi: 10.1590/1980-549720230022.2. eCollection 2023.
10
Ten Years’ Survival in Patients with Cervical Cancer and Related Factors in West Azerbaijan Province: Using of Cox Proportion Hazard Model.西阿塞拜疆省宫颈癌患者的十年生存率及相关因素:Cox比例风险模型的应用
Asian Pac J Cancer Prev. 2019 May 25;20(5):1345-1351. doi: 10.31557/APJCP.2019.20.5.1345.

引用本文的文献

1
Nomogram predicting overall survival in hospitalized cervical cancer patients in Mato Grosso, Brazil.巴西马托格罗索州住院宫颈癌患者总生存预测列线图
Discov Oncol. 2025 Jul 11;16(1):1312. doi: 10.1007/s12672-025-02380-y.
2
Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil.预测宫颈癌患者长期预后的列线图模型:巴西马托格罗索州的一项基于人群的研究
BMC Cancer. 2025 Apr 14;25(1):684. doi: 10.1186/s12885-025-14056-5.

本文引用的文献

1
Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.基于同期放化疗的治疗模式在 IIB 期宫颈鳞癌患者中的疗效。
BMC Cancer. 2024 Jan 18;24(1):106. doi: 10.1186/s12885-023-11372-6.
2
Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis.四个非洲国家 30-49 岁女性宫颈癌筛查的决定因素:一项横断面二次数据分析。
Cancer Control. 2023 Jan-Dec;30:10732748231195681. doi: 10.1177/10732748231195681.
3
Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer.
宫颈癌的诊断和个体化治疗挑战。
Medicina (Kaunas). 2023 May 11;59(5):925. doi: 10.3390/medicina59050925.
4
Ethnic-Regional Differences in the Allocation of High Complexity Spending in Brazil: Time Analysis 2010-2019.巴西高复杂度支出分配的种族-地区差异:2010-2019 年时间分析。
Int J Environ Res Public Health. 2023 Feb 9;20(4):3006. doi: 10.3390/ijerph20043006.
5
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.2020 年全球宫颈癌发病率和死亡率估计:世卫组织全球消除宫颈癌倡议的基线分析。
Lancet Glob Health. 2023 Feb;11(2):e197-e206. doi: 10.1016/S2214-109X(22)00501-0. Epub 2022 Dec 14.
6
Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea.巴氏涂片检查对宫颈癌患者长期生存的影响:韩国全国基于人群的队列研究。
Epidemiol Health. 2022;44:e2022072. doi: 10.4178/epih.e2022072. Epub 2022 Sep 7.
7
Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.宫颈癌预后及相关风险因素分析:一项长期回顾性队列研究。
Sci Rep. 2022 Aug 17;12(1):13994. doi: 10.1038/s41598-022-17733-8.
8
Cervical cancer specific survival in Grande Cuiabá, Mato Grosso State, Brazil.巴西马托格罗索州大库亚巴的宫颈癌特异性生存。
Rev Bras Epidemiol. 2022 Jun 24;25(Supl 1):e220017. doi: 10.1590/1980-549720220017.supl.1. eCollection 2022.
9
Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.从死亡时间到在埃塞俄比亚西北费莱吉比绍特综合专科医院的宫颈癌患者的预测因素:基于设施的回顾性随访研究。
PLoS One. 2022 Jun 24;17(6):e0269576. doi: 10.1371/journal.pone.0269576. eCollection 2022.
10
Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis.2014 年至 2019 年提克里阿贝贝萨专科医院宫颈癌患者死亡时间的预测因素:生存分析。
PLoS One. 2022 Feb 24;17(2):e0264369. doi: 10.1371/journal.pone.0264369. eCollection 2022.